# ELTROMBOPAG OLAMINE
> **ANDA220250** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2026-01-14
## Drug
- **FDA Application Number:** ANDA220250
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ELTROMBOPAG OLAMINE
- **Generic name:** ELTROMBOPAG OLAMINE
- **Active ingredients:** ELTROMBOPAG OLAMINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **Manufacturer:** Novadoz Pharmaceuticals LLC
- **First approval:** 2026-01-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220250)
---
*AI Analytics · CC0 1.0*